114 related articles for article (PubMed ID: 37464878)
21. 99mTc-depreotide in the evaluation of bone infection and inflammation.
Papathanasiou ND; Rondogianni PE; Pianou NK; Karampina PA; Vlontzou EA; Datseris IE
Nucl Med Commun; 2008 Mar; 29(3):239-46. PubMed ID: 18349794
[TBL] [Abstract][Full Text] [Related]
22. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.
Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP
Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993
[TBL] [Abstract][Full Text] [Related]
23. Conventional 99mTc-(hydroxy) methylene diphosphate remains useful to predict osteosarcoma response to neoadjuvant chemotherapy: Individual patient data and aggregate data meta-analyses.
Kubo T; Furuta T; Sakuda T; Ochi M; Adachi N
Medicine (Baltimore); 2018 Dec; 97(51):e13308. PubMed ID: 30572434
[TBL] [Abstract][Full Text] [Related]
24. Development of a novel 99mTc-chelate-conjugated bisphosphonate with high affinity for bone as a bone scintigraphic agent.
Ogawa K; Mukai T; Inoue Y; Ono M; Saji H
J Nucl Med; 2006 Dec; 47(12):2042-7. PubMed ID: 17138748
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the utility of
Gauguet JM; Pace-Emerson T; Grant FD; Shusterman S; DuBois SG; Frazier AL; Voss SD
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28449267
[TBL] [Abstract][Full Text] [Related]
26. Miniaturized Radiochemical Purity Testing for
Fuente A; Zanca R; Boni R; Cataldi AG; Sollini M; Lazzeri E; Mariani G; Erba PA
J Nucl Med Technol; 2017 Sep; 45(3):236-240. PubMed ID: 28705928
[TBL] [Abstract][Full Text] [Related]
27. [99mTc]cFLFLF for Early Diagnosis and Therapeutic Evaluation in a Rat Model of Acute Osteomyelitis.
Chen J; Cheng H; Dong Q; Chen F; Huang Z; Zhang Y; Pan D; Xiong W
Mol Imaging Biol; 2015 Jun; 17(3):337-44. PubMed ID: 25323104
[TBL] [Abstract][Full Text] [Related]
28. The impact of different bone tracers and acquisition times on image quality of equine bone scintigraphy.
Mageed M; Dyab S; Swagemakers JH; Gerlach K
Vet Radiol Ultrasound; 2022 Sep; 63(5):593-600. PubMed ID: 35666549
[TBL] [Abstract][Full Text] [Related]
29. [99mTc-HMDP accumulation in soft tissue tumor].
Momose M
Kaku Igaku; 2000 Nov; 37(6):639-43. PubMed ID: 11193449
[TBL] [Abstract][Full Text] [Related]
30. [Bone scintigraphy with 99mTc-hydroxymethylene diphosphonate (HMDP)--comparison with 99mtc-MDP (author's transl)].
Nakano S; Hasegawa Y; Shiomura K; Ibuka K; Hashizume T
Kaku Igaku; 1981 Dec; 18(10):1485-8. PubMed ID: 6210789
[No Abstract] [Full Text] [Related]
31. Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis.
Musumeci MB; Cappelli F; Russo D; Tini G; Canepa M; Milandri A; Bonfiglioli R; Di Bella G; My F; Luigetti M; Grandis M; Autore C; Perlini S; Perfetto F; Rapezzi C
JACC Cardiovasc Imaging; 2020 Jun; 13(6):1314-1321. PubMed ID: 31864976
[TBL] [Abstract][Full Text] [Related]
32. [Research of 99mTcO4- and 99mTcO2- in injectable solutions of 99mTc-HMDP by inverse phase HPTLC].
Jacquot Y; Zoubir B; Xicluna A; Bidet AC
Ann Pharm Fr; 2006 Jan; 64(1):63-7. PubMed ID: 16449940
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of technetium-99m hydroxymethylene diphosphonate scans in localizing bone metastases of differentiated thyroid carcinoma.
Tenenbaum F; Schlumberger M; Bonnin F; Lumbroso J; Aubert B; Benali H; Parmentier C
Eur J Nucl Med; 1993 Dec; 20(12):1168-74. PubMed ID: 8299652
[TBL] [Abstract][Full Text] [Related]
34. Intraosseous hemangiomatosis: technetium-99m(V)dimercaptosuccinic acid and technetium-99m-hydroxymethylene diphosphonate imaging.
Kobayashi H; Shigeno C; Sakahara H; Hosono M; Hosono M; Yao ZS; Endo K; Konishi J
J Nucl Med; 1994 Sep; 35(9):1482-4. PubMed ID: 8071696
[TBL] [Abstract][Full Text] [Related]
35. Technetium-99m human immunoglobulin scintigraphy in patients with adhesive capsulitis: a correlative study with bone scintigraphy.
Senocak O; Degirmenci B; Ozdogan O; Akalin E; Arslan G; Kaner B; Taşci C; Peker O
Ann Nucl Med; 2002 Jun; 16(4):243-8. PubMed ID: 12126093
[TBL] [Abstract][Full Text] [Related]
36. [Clinical evaluation of 99mTc-hydroxymethylene diphosphonate (HMDP) bone scintigraphy: comparison with 99mTc-MDP (author's transl)].
Honda H; Oshiumi Y; Kamoi I; Ichiya Y; Wada M; Matsuura K
Kaku Igaku; 1981 Nov; 18(9):1315-9. PubMed ID: 6461790
[No Abstract] [Full Text] [Related]
37. Comparison of Tc-99m methylene diphosphonate, Tc-99m human immune globulin, and Tc-99m-labeled white blood cell scintigraphy in the diabetic foot.
Unal SN; Birinci H; Baktiroğlu S; Cantez S
Clin Nucl Med; 2001 Dec; 26(12):1016-21. PubMed ID: 11711704
[TBL] [Abstract][Full Text] [Related]
38. Absent skeletal uptake of (99m)Tc-hydroxymethylene diphosphonate in the presence of AL-type amyloidosis associated with multiple myeloma.
Sasaki T; Okizaki A; Takahashi K; Mineta M; Nagasawa K; Fujimoto Y; Kohda K; Aburano T
Jpn J Radiol; 2011 Oct; 29(8):595-7. PubMed ID: 21928004
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Tc-99m HIG and three-phase Tc-99m MDP bone scintigraphy for evaluating the efficacy of Yttrium-90 silicate radionuclide synovectomy.
Arzu Gencoglu E; Aras G; Kucuk O; Atay G; Tutak I; Ataman S; Soylu A; Ibis E
Clin Nucl Med; 2003 Apr; 28(4):277-85. PubMed ID: 12642704
[TBL] [Abstract][Full Text] [Related]
40. What is the value of Tc-99m hydroxymethylene diphosphonate scintigraphy for the etiological diagnosis of mild rhabdomyolysis?
Esnault VL; Nakhla M; Delcroix C; Moutel MG; Couturier O
Clin Nucl Med; 2007 Jul; 32(7):519-23. PubMed ID: 17581334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
